-
Analyst Opinions
Africa Energy Transition Market Trends and Analysis by Sectors and Companies Driving Development
Africa Energy Transition Market Report Overview Africa is set to experience significant social, economic, and environmental changes that will heavily influence the region’s energy demand in the coming years. The power market in Africa still heavily relies on a combination of thermal power and large-scale hydropower projects to meet its power demand. However, the region’s energy transition is gaining pace as countries increasingly capitalize on the falling cost of producing renewable energy and the region’s rich renewable resources, which is...
-
Analyst Opinions
Oil and Gas Sector Strategies in Carbon Capture Utilization and Storage
Oil and Gas Sector Strategies in Carbon Capture Utilization and Storage Report Overview The total number of carbon capture utilization and storage (CCUS) projects was 66 in 2023. From 2023 to 2030, active CCUS capacity will increase at a CAGR of more than 37%. A strong increase in the number and maximum capacity of CCUS projects is expected as more commercial-scale projects become active in the coming years. CCUS will become an increasingly prominent emission reduction technology as the scale...
-
Sector Analysis
Asia Energy Transition Market Trends and Analysis by Sectors and Companies Driving Development
Asia Energy Transition Market Report Overview Asian countries have started pushing for policies and incentives that allow them to become leaders in the main energy transition sectors. Although they are moving quickly in developing renewable energy, further policies and actions need to be implemented to increase its competitiveness across the other four sectors. Energy supply is also the main sector responsible for CO2 emissions in the region. The Asia Energy Transition market research report provides analysis and trends on Asia’s energy transition...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Enasidenib Mesylate in Myelodysplastic Syndrome
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Enasidenib Mesylate in Myelodysplastic Syndrome Drug Details: Enasidenib mesylate (CC-90007, AG-221, Idhifa) is an anti...
-
Product Insights
New Lexington Mining Complex
The New Lexington Mining Complex is a coal mine in United States. It is currently in operation. Empower your strategies with our New Lexington Mining Complex report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons...
-
Product Insights
Tuscarawas County Mines
The Tuscarawas County Mines is a coal mine in United States. It is currently in operation. Empower your strategies with our Tuscarawas County Mines report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy...
-
Product Insights
Cadiz Mining Complex
The Cadiz Mining Complex is a coal mine in United States. It is currently in operation. Empower your strategies with our Cadiz Mining Complex report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Enasidenib Mesylate in Myeloproliferative Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Enasidenib Mesylate in Myeloproliferative Disorders report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Enasidenib Mesylate in Myeloproliferative Disorders Drug Details:Enasidenib mesylate (CC-90007, AG-221, Idhifa) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Enasidenib Mesylate in Cytopenia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Enasidenib Mesylate in Cytopenia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Enasidenib Mesylate in Cytopenia Drug Details:Enasidenib mesylate (CC-90007, AG-221, Idhifa) is an anti...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Enasidenib Mesylate in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Enasidenib Mesylate in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Enasidenib Mesylate in Acute Myelocytic Leukemia (AML,...